MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹8,300 Cr | ₹196 Cr | ₹163 Cr | ₹868 Cr | ₹235 Cr |
What is the latest Total Debt ratio of MANKIND PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹8,300 Cr |
| Mar2024 | ₹196 Cr |
| Mar2023 | ₹163 Cr |
| Mar2022 | ₹868 Cr |
| Mar2021 | ₹235 Cr |
How is Total Debt of MANKIND PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹8,300 Cr | 4,134.07 | |
| Mar2024 | ₹196 Cr | 20.54 | |
| Mar2023 | ₹163 Cr | -81.26 | |
| Mar2022 | ₹868 Cr | 270.12 | |
| Mar2021 | ₹235 Cr | - | |
Compare Total Debt of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹90,921.3 Cr | 1% | -0.2% | -24.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1% |
-0.2% |
-24.9% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses